In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.12 below Quidelortho Corp average.

Within In Vitro & In Vivo Diagnostic Substances industry 14 other companies have achieved higher Quick Ratio than Quidelortho in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 3300 to 3530.

Explain Quick Ratio?
How much Cash & cash equivalents QDEL�s has?
What are QDEL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

QDEL Quick Ratio	(Jun 28 2026) Q2	(Mar 29 2026) Q1	(Dec 28 2025) Q4	(Sep 28 2025) Q3	(Jun 29 2025) Q2
Y / Y Current Liabilities Change	-13.02 %	-8.1 %	-1.04 %	-25.25 %	22.49 %
Y / Y Cash & cash equivalent Change	-18.66 %	10.46 %	72.74 %	-31.73 %	41.78 %
Quick Ratio MRQ	0.12	0.15	0.17	0.13	0.13
QDEL's Total Ranking	# 3530	# 3300	# 2617	# 3000	# 0
Seq. Current Liabilities Change	3.22 %	-3.02 %	29.24 %	-32.76 %	9.06 %
Seq. Cash & cash equivalent Change	-12.11 %	-17.31 %	73.09 %	-35.33 %	19.35 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 15
Healthcare Sector	# 835
Overall Market	# 3530

Quick Ratio Statistics
High	Average	Low
6.86	1.89	0.1
(Jun 30 2016)		(Dec 29 2024)

Financial Statements
Quidelortho's Current Liabilities	$ 993 Millions	Visit QDEL's Balance sheet
Quidelortho's Cash & cash equivalent	$ 123 Millions	Visit QDEL's Balance sheet
Source of QDEL's Sales		Visit QDEL's Sales by Geography

Cumulative Quidelortho's Quick Ratio

QDEL's Quick Ratio for the trailling 12 Months

QDEL Quick Ratio	(Jun 28 2026) 12 Months	(Mar 29 2026) 12 Months	(Dec 28 2025) 12 Months	(Sep 28 2025) 12 Months	(Jun 29 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-11.93 %	-3.61 %	5.54 %	9.16 %	21.93 %
Y / Y Cash & cash equivalent TTM Growth	2.09 %	17.62 %	27.88 %	-4.29 %	-4.62 %
Quick Ratio TTM	0.14	0.14	0.14	0.12	0.12
Total Ranking TTM	# 4107	# 3976	# 3157	# 3086	# 0
Seq. Current Liabilities TTM Growth	-3.85 %	-2.15 %	-0.26 %	-6.15 %	5.23 %
Seq. Cash & cash equivalent TTM Growth	-5.05 %	2.43 %	15.05 %	-8.76 %	9.39 %

Quick ratio ranking by company, industry and sector >> Back to QDEL Financial Strength Comparisons >> Go to Compare QDEL Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in QDEL's Current Liabilities to $993.40 millions, cumulative Quick Ratio to 0.14 below the QDEL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within In Vitro & In Vivo Diagnostic Substances industry 14 other companies have achieved higher Quick Ratio than Quidelortho. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3976 to 4107.

Explain Quick Ratio?
How much Cash & cash equivalents QDEL�s has?
What are QDEL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the In Vitro & In Vivo Diagnostic Substances Industry	# 15
Healthcare Sector	# 909
Within the Market	# 4107

trailing twelve months Quick Ratio Statistics
High	Average	Low
6.08	1.84	0.11
(Sep 30 2016)		(Dec 29 2024)

Companies with similar Quick Ratio in the quarter ending Jun 28 2026, within In Vitro & In Vivo Diagnostic Substances Industry	Quick Ratio	Jun 28 2026 MRQ Cash & cash equivalent	Jun 28 2026 MRQ Current Liabilities
Volitionrx Limited	0.21	$ 2.800 Millions	$ 13.493 Millions
Neogen Corporation	0.20	$ 185.500 Millions	$ 916.900 Millions
Idexx Laboratories Inc	0.15	$ 196.933 Millions	$ 1,287.665 Millions
Quidelortho Corp	0.12	$ 123.400 Millions	$ 993.400 Millions
Aspira Women s Health inc	0.09	$ 0.477 Millions	$ 5.338 Millions

Date modified: 2026-09-08T20:21:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.